Stay updated on Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision displayed in the footer changes from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T11:45:55.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology, saying “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    0.4%
    Check dated 2026-10-26T11:13:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-19T11:59:40.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The website footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:20:11.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry v3.7.0, replacing the previous v3.6.6 entry. This reflects an update to the study record within the history table.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:27.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The study record's version history shows a new revision entry v3.6.6 added and the previous v3.6.5 removed, indicating a page version update in the history log.
    Difference
    0.1%
    Check dated 2026-08-31T16:52:59.000Z thumbnail image

Stay in the know with updates to Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Favezelimab Combo vs Standard in Metastatic CRC Clinical Trial page.